Chronic Hepatitis C Infection Has No Effect on Peripheral CD4⁺CD25⁺ Tregulatory Cells in Patients with End-Stage Renal Disease

References

• Afzali B, Edozie FC, Fazekasova H, Scotta C, Mitchell PJ, Canavan JB, Kordasti SY, Chana PS, Ellis R, Lord GM, et al. 2013. Comparison of regulatory t cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation. Clin J Am Soc Nephrol. 8:1396–405.
   PubMed Web of Science ®Google Scholar
• Azimi M, Aslani S, Mortezagholi S, Salek A, Javan MR, Rezaiemanesh A, Ghaedi M, Gholamzad M, Salehi E. 2016. Identification, isolation, and functional assay of regulatory T cells. Immunol Invest. 45(7):584–602.
   PubMed Web of Science ®Google Scholar
• Battaglia M, Roncarolo MG. 2011. Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes. Semin Immunol. 23(3):182–94.
   PubMed Web of Science ®Google Scholar
• Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, Haller M, Rockell J, Gottlieb P, Clare-Salzler M, et al. 2007. No alterations in the frequency of foxp3+ regulatory t-cells in type 1 diabetes. Diabetes. 56(3):604–12.
   PubMed Web of Science ®Google Scholar
• Caprara C, Kinsey GR, Corradi V, Xin W, Ma JZ, Scalzotto E, Martino FK, Okusa MD, Nalesso F, Ferrari F. 2016. The influence of hemodialysis on t regulatory cells: a meta-analysis and systematic review. Blood Purif. 42:307–13.
   PubMed Web of Science ®Google Scholar
• Corthay A. 2009. How do regulatory t cells work? Scand J Immunol. 70:326–36.
   PubMed Web of Science ®Google Scholar
• Ducloux D, Legendre M, Bamoulid J, Rebibou J-M, Saas P, Courivaud C, Crepin T. 2018. ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications. Immun Ageing. 15:16.
   PubMed Web of Science ®Google Scholar
• Ebinuma H, Nakamoto N, Li Y, Price DA, Gostick E, Levine BL, Tobias J, Kwok WW, Chang K-M. 2008. Identification and in vitro expansion of functional antigen-specific cd25+ foxp3+ regulatory t cells in hepatitis c virus infection. J Virolo. 82:5043–53.
   PubMed Web of Science ®Google Scholar
• Gregori S, Goudy KS, Roncarolo MG. 2012. The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory t cells. Front Immunol. 3:30.
   PubMed Web of Science ®Google Scholar
• Hendrikx TK, van Gurp EA, Mol WM, Schoordijk W, Sewgobind VD, Ijzermans JN, Weimar W, Baan CC. 2009. End-stage renal failure and regulatory activities of cd4+cd25bright+foxp3+ t-cells. Nephrol Dial Transplant. 24:1969–78.
   PubMed Web of Science ®Google Scholar
• Herrera-Gomez F, Vasquez-Seoane M, Del Aguila W, Martin-Garcia D, Maurtua-Briseno Meiggs A, Gonzalez-Lopez A, Andrés-Martín B, Nava-Rebollo Á, Casquero-Fernández F, Pascual-Núñez P, et al. 2017. Peripheral blood regulatory t cell counts as a predictive biomarker for the outcome of kidney transplant: a systematic review. Med Clin (Barc). 149:523–35.
   PubMed Web of Science ®Google Scholar
• Irshad M, Gupta P, Irshad K. 2019. Immunopathogenesis of liver injury during hepatitis c virus infection. Viral Immunol. 32:112–20.
   PubMed Web of Science ®Google Scholar
• Jung MK, Shin EC. 2016. Regulatory t cells in hepatitis b and c virus infections. Immune Netw. 16:330–36.
   PubMed Web of Science ®Google Scholar
• Karkhah A, Javanian M, Ebrahimpour SJI. 2018. The role of regulatory t cells in immunopathogenesis and immunotherapy of viral infections. Genet Evol. 59:32–37.
   PubMed Web of Science ®Google Scholar
• Keoshkerian E, Hunter M, Cameron B, Nguyen N, Sugden P, Bull R, Zekry A, Maher L, Seddiki N, Zaunders J, et al. 2016. Hepatitis c-specific effector and regulatory cd4 t-cell responses are associated with the outcomes of primary infection. J Viral Hepat. 23:985–93.
   PubMed Web of Science ®Google Scholar
• Laftavi MR, Sharma R, Feng L, Said M, Pankewycz O. 2014. Induction therapy in renal transplant recipients: a review. Immunol Invest. 43:790–806.
   PubMed Web of Science ®Google Scholar
• Lavanchy D. 2011. Evolving epidemiology of hepatitis c virus. Clin Microbiol Infect. 17:107–15.
   PubMed Web of Science ®Google Scholar
• Li H, Li T, Crispe IN, Tu Z. 2018. Hcv immune evasion and regulatory t cell activation: cause or consequence? Cell Mol Immunol. 15:536–38.
   PubMed Web of Science ®Google Scholar
• Libetta C, Esposito P, Sepe V, Portalupi V, Margiotta E, Canevari M, Dal Canton A. 2010. Dialysis treatment and regulatory t cells. Nephrol Dial Transplant. 25:1723–27.
   PubMed Web of Science ®Google Scholar
• Lin F-J, Jiang G-R, Shan J-P, Zhu C, Zou J, Wu X-R. 2012. Imbalance of regulatory t cells to th17 cells in IgA nephropathy. Scand J Clin Lab Invest. 72:221–29.
   PubMed Web of Science ®Google Scholar
• Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. 2005. Defective suppressor function in cd4+ cd25+ t-cells from patients with type 1 diabetes. Diabetes. 54:92–99.
   PubMed Web of Science ®Google Scholar
• Lisowska KA, Dębska-Ślizień A, Jasiulewicz A, Bryl E, Witkowski JM. 2014. Influence of hemodialysis on circulating cd4lowcd25high regulatory t cells in end-stage renal disease patients. Inflam Res. 63:99–103.
   PubMed Web of Science ®Google Scholar
• Litjens NH, Boer K, Zuijderwijk JM, Klepper M, Peeters AM, Verschoor W, Kraaijeveld R, Betjes MG. 2017. Natural regulatory t cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific tregs. Kidney Int. 91:1203–13.
   PubMed Web of Science ®Google Scholar
• Liu W, Almo SC, Zang X. 2016. Co-stimulate or co-inhibit regulatory t cells, which side to go? Immunol Invest. 45:813–31.
   PubMed Web of Science ®Google Scholar
• Mathew RO, Mason DL, Song R, Tryniszewski T, Kennedy JS. 2016. Role of t‐regulatory cells in the response to hepatitis b vaccine in hemodialysis patients. Hemodial Int. 20:242–52.
   PubMed Web of Science ®Google Scholar
• Meier P, Golshayan D, Blanc E, Pascual M, Burnier M. 2009. Oxidized LDL modulates apoptosis of regulatory t cells in patients with ESRD. Clin J Am Soc Nephrol. 20:1368–84.
   Web of Science ®Google Scholar
• Rodríguez-Perea AL, Arcia ED, Rueda CM, Velilla PA. 2016. Phenotypical characterization of regulatory t cells in humans and rodents. Clin Exp Immunol. 185:281–91.
   PubMed Web of Science ®Google Scholar
• Romano M, Fanelli G, Albany CJ, Giganti G, Lombardi G. 2019. Past, present, and future of regulatory t cell therapy in transplantation and autoimmunity. Front Immunol. 10:43.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Miyara M, Costantino CM, Hafler DA. 2010. Foxp3+ regulatory t cells in the human immune system. Nat Rev Immunol. 10:490–500.
   PubMed Web of Science ®Google Scholar
• Schaier M, Leick A, Uhlmann L, Kälble F, Morath C, Eckstein V, Ho A, Mueller‐Tidow C, Meuer S, Mahnke K, et al. 2018. End‐stage renal disease, dialysis, kidney transplantation and their impact on cd 4+ t‐cell differentiation. Immunology. 155:211–24.
   PubMed Web of Science ®Google Scholar
• Sharma A, Rudra D. 2019. Regulatory t cells as therapeutic targets and mediators. Int Rev Immunol. 1–21. doi:10.1080/08830185.2019.1621310
   PubMed Web of Science ®Google Scholar
• Stevenson TJ, Barbour Y, McMahon BJ, Townshend-Bulson L, Hewitt AM, Espera HG, Homan C, Holck P, S V L, Knall C, et al. 2019. Observed changes in NK and T cell phenotypes and predictors of immune outcome following sofosbuvir-based therapy for chronic HCV infection in a longitudinal cohort. Open Forum Infect Dis. 6(6). doi:10.1093/ofid/ofz223
   Web of Science ®Google Scholar
• Tanaka A, Sakaguchi S. 2016. Regulatory t cells in cancer immunotherapy. Cell Res. 27:109.
   PubMed Web of Science ®Google Scholar
• Topal C, Köksoy S, Süleymanlar G, Yakuboğlu G, Ersoy FF. 2013. Peripheral treg count and it’s determinants in unsensitized and sensitized chronic kidney disease patients. Int Urol Nephrol. 45:1647–52.
   PubMed Web of Science ®Google Scholar
• Tseng K-C, Ho Y-C, Hsieh Y-H, Lai N-S, Wen Z-H, Li C, Wu S-F. 2012. Elevated frequency and function of regulatory t cells in patients with active chronic hepatitis c. J Gastroenterol. 47:823–33.
   PubMed Web of Science ®Google Scholar
• Wang J, Ioan‐Facsinay A, Van der Voort EI, Huizinga TW, Toes R. 2007. Transient expression of foxp3 in human activated nonregulatory cd4+ t cells. Eur J Immunol. 37:129–38.
   PubMed Web of Science ®Google Scholar
• Yoshizawa K, Abe H, Kubo Y, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y. 2010. Expansion of cd4+ cd25+ foxp3+ regulatory t cells in hepatitis c virus‐related chronic hepatitis, cirrhosis and hepatocellular carcinoma. Hepatol Res. 40:179–87.
   PubMed Web of Science ®Google Scholar
• Yu H, Paiva R, Flavell RA. 2018. Harnessing the power of regulatory t-cells to control autoimmune diabetes: overview and perspective. Immunology. 153:161–70.
   PubMed Web of Science ®Google Scholar
• Zaza G, Granata S, Rascio F, Pontrelli P, Dell’Oglio MP, Cox SN, Pertosa G, Grandaliano G, Lupo A. 2013. A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. BMC Med Genomics. 6:17.
   PubMed Web of Science ®Google Scholar